Springworks Therapeutics Is A Biopharmaceutical Company Based In Stamfordconnecticutdedicated To Developing Precision Medicines For Rare Diseases And Cancersfounded In 2017The Company Focuses On Targeted Oncology Therapiesparticularly For Conditions With Limited Treatment Optionsspringworks Collaborates With Industry Leadersacademic Institutionsand Patient Advocacy Groups To Enhance Its Research And Development Efforts The Companyae S Key Products Include Ogsiveonirogacestat An Oral Gamma Secretase Inhibitor Approved For Treating Desmoid Tumorsand Gomeklimirdametinib A Mek1 2 Inhibitor In Development For Neurofibromatosis Type 1 Associated Plexiform Neurofibromasspringworks Is Also Advancing Several Pipeline Candidates Targeting Various Cancersincluding Ovarian Granulosa Cell Tumors And Low Grade Gliomasthe Company Emphasizes A Patient Centric Approach And Is Recognized As A Certified Great Place To Worka Reflecting Its Commitment To Employee Engagement And Innovation
